| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.045 | 0.8 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.04 | 0.8 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.029 | 0.8 |